RNS Number : 7803D
GlaxoSmithKline PLC
21 February 2020
GlaxoSmithKline plc
(the '
Company
')
Transaction notification
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
|
|
a)
|
Name
|
Ms V Whyte
|
|
b)
|
Position/status
|
Company Secretary
|
|
c)
|
Initial notification/
amendment
|
Initial Notification
|
|
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
|
|
a)
|
Descriptionofthe
financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
|
|
b)
|
Nature
ofthe
transaction
|
Transfer of 10,720 Ordinary Shares between accounts for nil consideration.
|
|
c)
|
Price(s)and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
£0.00
|
10,720
|
|
|
|
|
|
|
|
d)
|
Aggregated
information
|
N/A (single transaction)
|
|
Aggregated
volume
Price
|
|
|
e)
|
Date ofthe
transaction
|
2020-02-20
|
|
f)
|
Placeofthe transaction
|
N/A
|
|
1.
|
Details of PDMR/person closely associated with them ('PCA')
|
|
a)
|
Name
|
Ms V Whyte
|
|
b)
|
Position/status
|
Company Secretary
|
|
c)
|
Initial notification/
amendment
|
Initial Notification
|
|
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
|
|
a)
|
Descriptionofthe
financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
|
|
b)
|
Nature
ofthe
transaction
|
Transfer of 10,838 Ordinary Shares to spouse for nil consideration.
|
|
c)
|
Price(s)and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
£0.00
|
10,838
|
|
|
|
|
|
|
|
d)
|
Aggregated
information
|
N/A (single transaction)
|
|
Aggregated
volume
Price
|
|
|
e)
|
Date ofthe
transaction
|
2020-02-20
|
|
f)
|
Placeofthe transaction
|
N/A
|
|
|
Details of PDMR/person closely associated with them ('PCA')
|
|
a)
|
Name
|
Mr I Whyte
|
|
b)
|
Position/status
|
PCA of Ms V Whyte (Company Secretary)
|
|
c)
|
Initial notification/
amendment
|
Initial Notification
|
|
2.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
|
|
a)
|
Descriptionofthe
financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
|
|
b)
|
Nature
ofthe
transaction
|
Receipt of 10,838 Ordinary Shares from spouse for nil consideration.
|
|
c)
|
Price(s)and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
|
|
£0.00
|
10,838
|
|
|
|
|
|
|
|
d)
|
Aggregated
information
|
N/A (single transaction)
|
|
Aggregated
volume
Price
|
|
|
e)
|
Date ofthe
transaction
|
2020-02-20
|
|
f)
|
Placeofthe transaction
|
N/A
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
DSHLFLFLBLLEBBK